Nine Masts Capital »

Acumen Pharmaceuticals shares owned by Nine Masts Capital

Quarter-by-quarter ownership of Acumen Pharmaceuticals (ABOS) shares owned by Nine Masts Capital from 13F filings

Historical chart of Nine Masts Capital investment in Acumen Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acumen Pharmaceuticals held by Nine Masts Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acumen Pharmaceuticals by Nine Masts Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $22k 11k 2.11

More positions owned by Nine Masts Capital

Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Norfolk Southern (NSC)
Fox Corp Cl B Com (FOX)
Invesco Qqq Tr Unit Ser 1 (Principal) (QQQ)
Cyberark Software SHS (CYBR)
Nio Note 4.625%10/1 (Principal)
Qorvo (QRVO)
Ase Technology Hldg Sponsored Ads (ASX)
GSK Sponsored Adr (GSK)
Zillow Group Cl C Cap Stk (Z)
EXACT Sciences Corporation (EXAS)
Ryanair Holdings Sponsored Adr (RYAAY)
Jd.com Spon Ads Cl A (JD)

View all positions for Nine Masts Capital

Top funds holding Acumen Pharmaceuticals

RA Capital Management
Sands Capital Ventures
Franklin Resources
FMR
Vanguard Group
Knollwood Investment Advisory
Alyeska Investment Group
ADAR1 Capital Management
Laurion Capital Management
Pathstone Holdings
Hudson Bay Capital Management
Millennium Management
Citadel Advisors
Two Sigma Advisers
Renaissance Technologies

View all funds holding Acumen Pharmaceuticals